Draxis Health Inc /CN/ - Report of Foreign Issuer (6-K)
14 Maio 2008 - 4:27PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
Pursuant
to Rule 13a-16 or 15-d-16 of
The
Securities Exchange Act of 1934
For
May 14, 2008
Commission
File Number 000-17434
DRAXIS HEALTH INC.
(Translation
of registrants name into English)
Suite 4700,
TD Bank Tower
Toronto
Dominion Centre
Toronto,
Ontario M5K 1E6
CANADA
(Address
of principal offices)
Registrant
files annual reports under cover of Form 20-F
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
DRAXIS
HEALTH INC.
|
|
|
|
|
|
By:/s/
Alida Gualtieri
|
|
General
Counsel & Secretary
|
Dated: May 14,
2008
2
Draxis Health (MM) (NASDAQ:DRAX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Draxis Health (MM) (NASDAQ:DRAX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Draxis Health (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Draxis Health Inc /CN/